Trellus Management Company, LLC Agenus Inc Transaction History

Trellus Management Company, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 25, 2022	BUY	$1.96 - $3.14 $1.18 Million - $1.88 Million	600,000 New	600,000 $1.23 Million
Q4 2020 Feb 10, 2021	SELL	$3.17 - $4.49 $2.38 Million - $3.37 Million	-750,000 Closed	0 $0
Q3 2020 Oct 20, 2020	BUY	$2.98 - $5.2 $1.31 Million - $2.29 Million	440,000 Added 141.94%	750,000 $3 Million
Q2 2020 Aug 12, 2020	BUY	$2.29 - $4.24 $480,900 - $890,400	210,000 Added 210.0%	310,000 $1.22 Million
Q1 2020 May 06, 2020	BUY	$1.92 - $4.39 $192,000 - $438,999	100,000 New	100,000 $245,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Trellus Management Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Trellus Management Company, LLC with notifications on news.